WO2003092632A3 - Agents anticancereux de peptides cycliques et leurs procedes d'utilisation - Google Patents
Agents anticancereux de peptides cycliques et leurs procedes d'utilisation Download PDFInfo
- Publication number
- WO2003092632A3 WO2003092632A3 PCT/US2003/014373 US0314373W WO03092632A3 WO 2003092632 A3 WO2003092632 A3 WO 2003092632A3 US 0314373 W US0314373 W US 0314373W WO 03092632 A3 WO03092632 A3 WO 03092632A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer agents
- methods
- cyclic peptide
- peptide anti
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003232077A AU2003232077A1 (en) | 2002-05-06 | 2003-05-06 | Cyclic peptide anti-cancer agents and methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37839502P | 2002-05-06 | 2002-05-06 | |
US60/378,395 | 2002-05-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003092632A2 WO2003092632A2 (fr) | 2003-11-13 |
WO2003092632A3 true WO2003092632A3 (fr) | 2007-11-01 |
Family
ID=29401603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/014373 WO2003092632A2 (fr) | 2002-05-06 | 2003-05-06 | Agents anticancereux de peptides cycliques et leurs procedes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003232077A1 (fr) |
WO (1) | WO2003092632A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085777A2 (fr) | 2000-05-09 | 2001-11-15 | Greenville Hospital System | Peptides therapeutiques formant des pores |
US7456146B2 (en) * | 2001-05-09 | 2008-11-25 | Ghc Research Development Corporation | Lytic peptide prodrugs |
WO2010051667A1 (fr) * | 2008-11-10 | 2010-05-14 | 复旦大学 | Compositions pharmaceutiques comprenant des nanotubes de peptide cyclique et utilisations de celles-ci |
ES2342874B2 (es) * | 2010-02-19 | 2011-01-27 | Fundacio Privada Institut D'investigacio Biomedica De Girona Dr. Josep Trueta | Peptidos ciclicos inhibidores del crecimiento celular. |
WO2013025099A1 (fr) * | 2011-08-17 | 2013-02-21 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Substrats pour la détection de périopathogènes de la cavité buccale |
CN104583229B (zh) * | 2012-08-29 | 2020-06-16 | 新加坡科技研究局 | 肽及其应用 |
CA2908552A1 (fr) * | 2013-04-02 | 2014-10-09 | The Scripps Research Institute | Utilisations de peptides cycliques pour traiter et prevenir l'atherosclerose |
DK3149025T3 (da) | 2014-05-21 | 2019-07-22 | Entrada Therapeutics Inc | Cellepenetrerende peptider og fremgangsmåder til frembringelse og anvendelse deraf |
US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
EP3185880B1 (fr) | 2014-08-27 | 2020-02-12 | Ohio State Innovation Foundation | Inhibiteurs améliorés de la peptidyl-calcineurine |
WO2016115140A1 (fr) * | 2015-01-13 | 2016-07-21 | Boston Scientific Scimed, Inc. | Dépolarisation de membranes de cellules cancéreuses |
CN106699841B (zh) * | 2017-01-05 | 2020-07-24 | 北京大学深圳研究生院 | 一种自组装的多肽纳米棒及其制备方法 |
EP3749365A4 (fr) | 2018-01-29 | 2022-01-12 | Ohio State Innovation Foundation | Inhibiteurs peptidyliques de l'interaction calcineurine-nfat |
CA3092062A1 (fr) | 2018-02-22 | 2019-08-29 | Entrada Therapeutics, Inc. | Compositions et methodes de traitement de l'encephalopathie mitochondriale neurogastro-intestinale |
WO2019217682A1 (fr) | 2018-05-09 | 2019-11-14 | Ohio State Innovation Foundation | Peptides cycliques de pénétration cellulaire avec un ou plusieurs résidus hydrophobes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096707A (en) * | 1997-07-11 | 2000-08-01 | Biotie Therapies Ltd. | Integrin binding peptide and use thereof |
US6277818B1 (en) * | 1998-10-29 | 2001-08-21 | Angstrom Pharmaceuticals, Inc. | Cyclic peptide ligands that target urokinase plasminogen activator receptor |
-
2003
- 2003-05-06 WO PCT/US2003/014373 patent/WO2003092632A2/fr not_active Application Discontinuation
- 2003-05-06 AU AU2003232077A patent/AU2003232077A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096707A (en) * | 1997-07-11 | 2000-08-01 | Biotie Therapies Ltd. | Integrin binding peptide and use thereof |
US6277818B1 (en) * | 1998-10-29 | 2001-08-21 | Angstrom Pharmaceuticals, Inc. | Cyclic peptide ligands that target urokinase plasminogen activator receptor |
Also Published As
Publication number | Publication date |
---|---|
AU2003232077A8 (en) | 2003-11-17 |
WO2003092632A2 (fr) | 2003-11-13 |
AU2003232077A1 (en) | 2003-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003011115A3 (fr) | Agents de contraste multimères ciblés à base de peptides | |
AU2003247798A1 (en) | Nozzles and components thereof and methods for making the same | |
WO2004058159A3 (fr) | Composes immunomodulateurs ramifies et leur procedes d'utilisation | |
EP1660638A4 (fr) | Lipoparticules comprenant des proteines, et procedes de production et d'utilisation de ces lipoparticules | |
IL212752A0 (en) | An molecule directed against the ??-secretase cleavage site of amyloid precursor protein, and uses thereof | |
AU2003299585A8 (en) | Water-soluble products and methods of making and using the same | |
IL171109A (en) | Glycopagilization methods and proteins / peptides produced by these methods | |
WO2003077867A3 (fr) | Compositions a base de chlorhydrate de naltrexone | |
AU2003212458A1 (en) | Cyclo(n)pyrroles and methods thereto | |
WO2003103571A3 (fr) | Vaccins contre les flavivirus | |
WO2003092632A3 (fr) | Agents anticancereux de peptides cycliques et leurs procedes d'utilisation | |
WO2003104425A3 (fr) | Nouveaux anticorps anti-cd22 stables | |
WO2004009616A3 (fr) | Analogues de la ghreline | |
AU2003295843A8 (en) | Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same | |
WO2004052312A3 (fr) | Agents anti-infectieux | |
WO2003031585A3 (fr) | Molecules d'acide nucleique codant une serine protease transmembranaire 25, polypeptides codes et procedes connexes | |
WO2003092631A3 (fr) | Agents antiviraux de peptides cycliques et leurs procedes d'utilisation | |
WO2005087932A3 (fr) | Vecteurs pour le clonage directionnel | |
AU2003206367A1 (en) | Technical field of the invention | |
WO2004050613A3 (fr) | Derives de 3-propenamide substitue en 2 et procedes d'utilisation de ces derives | |
WO2004016640A3 (fr) | Intermediaires de 5 androstene-3?-ol steroides et leurs procedes de preparation | |
WO2004019965A3 (fr) | Approches tolerogenes a base de thymus destinees au diabete de type i. | |
WO2004047751A3 (fr) | Composes calcilytiques | |
EP1517879A4 (fr) | Aminoalkylphenols et leurs procedes d'utilisation et de fabrication | |
AU2002330245A1 (en) | Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |